Drug Development

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Articles

Targeted polymeric nanoparticles are an important vehicle for controlling and targeting dosing of chemotherapeutic agents.

Formulation Development Forum: Targeted Polymeric Nanoparticles

Advances in palladium-catalyzed hydrogenation, visible-light photocatalysis, and chemocatalyisis for heterocycles are some recent developments.

Seeking Chemocatalytic and Biocatalytic Solutions

Amy Ritter was Scientific Editor, BioPharm International.

In this technical forum, experts describe different methods of rapid microbial testing and their applications.

Rapid Microbial Testing

Contract API manufacturers and fine-chemical producers roll out capacity and service expansions.

Inside INFORMEX: Evaluating the Market for Contract API Manufacturing

Excipient manufacturers expand production capacity and partner to broaden their offerings.

Expanding Excipient Portfolios

On Mar. 7, 2012, GE Healthcare announced an agreement to acquire Xcellerex, a supplier of manufacturing technologies for the biopharmaceutical industry, for an undisclosed amount.

GE Healthcare to Acquire Xcellerex

Regulatory bodies, standard-setting organizations, and industry seek to tackle the problem of counterfeit drugs and securing the flow of pharma ingredients.

Securing the Pharma Supply Chain

The author reviews significant changes to GMP for excipients in the forthcoming American National Standard, including a risk-based approach to excipient manufacture, why new requirements were proposed, and their potential impact to excipient manufacturers.

The American National Standard for Excipient GMP

This article provides guidance for industry on how to comply with the pending American National Standard on excipient GMP, with a focus on risk assessment.

Standardized Excipient GMP

As biopharmaceutical development and commercialization increases, companies are expanding their cold-chain capabilities.

APIs and Excipients